Cargando…
Research progress on common adverse events caused by targeted therapy for colorectal cancer
As targeted drug therapy is increasingly applied in the treatment of colon cancer, understanding and managing the adverse reactions of patients is becoming increasingly important. The present review examines the mechanisms of and adverse reactions to the most commonly used targeted drugs for colon c...
Autores principales: | Zhang, Bo, Fang, Chenyan, Deng, Dehou, Xia, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006412/ https://www.ncbi.nlm.nih.gov/pubmed/29928383 http://dx.doi.org/10.3892/ol.2018.8651 |
Ejemplares similares
-
Progress of research on molecular targeted therapies for colorectal cancer
por: Huang, Shilin, et al.
Publicado: (2023) -
Adverse events of targeted therapies approved for women's cancers
por: Saint-Ghislain, Mathilde, et al.
Publicado: (2021) -
Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer
por: Fakih, M., et al.
Publicado: (2010) -
Risk of Thromboembolic Events and Major Adverse Cardiovascular Events Following Antivascular Endothelial Growth Factor Therapy in Patients with Colorectal Cancer
por: Chen, Yen-Cheng, et al.
Publicado: (2022) -
Use and misuse of common terminology criteria for adverse events in cancer clinical trials
por: Zhang, Sheng, et al.
Publicado: (2016)